Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 15Unknown 4Withdrawn 2Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2

Conditions

Leukemia, Myeloid, Acute 25Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Leukemia 9Lymphoma, Large B-Cell, Diffuse 8Lymphoma 8Burkitt Lymphoma 6Recurrence 5Lymphoma, Follicular 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large-Cell, Anaplastic 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Leukemia, Biphenotypic, Acute 4Sezary Syndrome 3Myelodysplastic Syndromes 3Mycosis Fungoides 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Lymphocytic, Chronic, B-Cell 3Immunoblastic Lymphadenopathy 3Hodgkin Disease 3Blast Crisis 3Waldenstrom Macroglobulinemia 2Lymphoma, T-Cell, Peripheral 2Lymphoma, Extranodal NK-T-Cell 2Lymphoma, B-Cell 2Lymphoma, AIDS-Related 2Leukemia, Myelomonocytic, Chronic 2

Interventions

Peripheral Blood Stem Cell Transplantation 7Cyclosporine 6Methotrexate 5fludarabine phosphate 4Cyclophosphamide 4Busulfan 4Tacrolimus 3Radiotherapy 3Whole-Body Irradiation 2Pentetic Acid 2Mycophenolic Acid 2Idarubicin 2Filgrastim 2Cytarabine 2Cyclosporins 2Antilymphocyte Serum 2merphos 1ethanolamine oleate 1Trimethoprim, Sulfamethoxazole Drug Combination 1Trimethoprim 1Therapeutics 1Sulfamethoxazole 1Sodium Chloride 1Saline Solution, Hypertonic 1Saline Solution 1Pentostatin 1Minocycline 1Methylprednisolone 1Melphalan 1Interferon-gamma 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Leukemia, Myeloid, Chronic-Phase × Cytarabine × Clear all
NCT00004878 2020-07-31

Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia

Jonsson Comprehensive Cancer Center

Phase 2 Withdrawn
MyeloidOther hematologic neoplasm

Graft vs Host Disease, Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase

NCT00002761 2012-11-19

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia

Columbia University

Phase 1/2 Withdrawn
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡